Author:
Nomura Motoo,Oze Isao,Abe Tetsuya,Komori Azusa,Narita Yukiya,Masuishi Toshiki,Taniguchi Hiroya,Kadowaki Shigenori,Ura Takashi,Andoh Masashi,Kawai Ryosuke,Uemura Norihisa,Ishihara Makoto,Tanaka Tsutomu,Tajika Masahiro,Niwa Yasumasa,Muro Kei,Muto Manabu
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference15 articles.
1. Tachimori Y, Ozawa S, Numasaki H et al (2015) Comprehensive registry of esophageal cancer in Japan, 2008. Esophagus 12:130–157
2. Ando N, Iizuka T, Ide H et al (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol 21:4592–4596
3. Ando N, Kato H, Igaki H et al (2012) A randomized trial CF postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). Ann Surg Oncol 19:68–74
4. Ura T, Nagase M, Fujii H et al (2010) Feasibility study of preoperative docetaxel (D), cisplatin (C), and fluorouracil (F) in esophageal cancer. ASCO Gastrointestinal Cancers Symposium, abstr 81
5. Hara H, Tahara M, Daiko H et al (2013) Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma. Cancer Sci 104:1455–1460
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献